ResearcherThe University of SydneyNo recent work listed

Phil Townend

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5054551918. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper

Papers 1

Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: analysis of early outcome data. Co-author DOI 10.1111/ans.13897 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jaswinder Singh Samra · 1 shared paper, 2018 · strength 0.09
- Paper Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: an… DOI 10.1111/ans.13897 ↗
Nick Pavlakis · 1 shared paper, 2018 · strength 0.09
- Paper Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: an… DOI 10.1111/ans.13897 ↗
Terence C. Chua · 1 shared paper, 2018 · strength 0.09
- Paper Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: an… DOI 10.1111/ans.13897 ↗
Anthony James Gill · 1 shared paper, 2018 · strength 0.09
- Paper Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: an… DOI 10.1111/ans.13897 ↗
Anubhav Mittal · 1 shared paper, 2018 · strength 0.09
- Paper Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: an… DOI 10.1111/ans.13897 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.